Qilu Puget Sound Biotherapeutics (dba Sound Biologics) clinical trials
A subsidiary of Qilu Pharmaceutical Co., Ltd.
The registry lists 2 studies whose lead sponsor is Qilu Puget Sound Biotherapeutics (dba Sound Biologics). 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 28, 2022.
Registry sponsor names on this page
- Qilu Puget Sound Biotherapeutics (dba Sound Biologics)2 studies
Something wrong with this grouping? Tell us on the Qilu Pharmaceutical Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Qilu Pharmaceutical Co., Ltd. studies →
- PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell MalignanciesStatus unknownNCT05003141Phase 1
Sponsor listed in the registry: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
- A Study of PSB205 in Subjects With Advanced Solid TumorsStatus unknownNCT03986606Phase 1
Sponsor listed in the registry: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)